Becton Dickinson is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories and the industry.

Medical Devices

Becton Dickinson

Herman Cueto serves as Senior Vice President of Finance for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, Cueto is responsible for oversight of the financial operations for: BD's Medical, Interventional and Life Sciences Segments; Business Planning and Analysis; BD's Integrated Supply Chain function, one of the company's largest functions; as well as all BD regions. He is also a member of the BD Executive Leadership Team.

Cueto joined BD in 2017 through the acquisition of C.R. Bard, where he worked in various finance and leadership roles since 2004, including those within corporate, international and supply chain operations. Prior to his current role, Cueto held several positions at BD including Chief Financial Officer for BD’s Medical Segment and Interventional Segment, respectively. Cueto has more than 25 years of experience in finance and business planning.

Cueto earned a Bachelor of Science and master’s degree from Fairleigh Dickinson University and a Master of Business Administration degree from Seton Hall University. He is also a Certified Public Accountant in New Jersey.

Herman Cueto

Jeffrey W. Henderson

Tony Ezell serves as executive vice president of North America and chief marketing officer for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he leads the U.S. and Canada regions and the Global Marketing organization and is responsible for an integrated commercialization approach to how we address and prioritize customer needs. He is also a member of the BD Executive Leadership Team.

Prior to BD, Ezell spent more than 27 years at Eli Lilly and Co., where he built a strong track record in sales, marketing and business leadership, having led global market research before assuming the role of chief customer officer. He went on to serve as chief marketing officer for Lilly’s Elanco Animal Health business prior to its spinoff and most recently led Lilly’s U.S. Connected Care and Insulins business as VP/GM.

Ezell has global operational experience, having lead organizations as large as 1,200. Additionally, he has a passion for people, as demonstrated by his history of building high performing teams and by his history of developing deep customer understanding and translating that understanding into meaningful brand campaigns. He is experienced in leading major transformation that spans business units, functions and geographies. Tony currently serves on the Board of Trustees for Brebeuf Jesuit High School. He is a former member of the Board of Directors for the Catholic Medical Mission Board and the KPMG Healthcare Advisory Board. He is also the former Chairman of the UNCF Indianapolis Leadership Council. He served on the Board of Directors for the Health Forum, Inc. from 2006 to 2012.

He has a degree in Business Administration from the School of Business and Industry (SBI) at Florida A & M University, an Executive Education Certificate from Wharton and an MBA from the Kellogg School of Management at Northwestern University.

Tony Ezell

Dr. William (Bill) Sigmund joined BD in January 2018 as executive vice president and chief medical officer. He is accountable for the company’s medical affairs organization, which includes the medical group for each business unit, global clinical development and the Medical Safety Office. He is also a member of the BD Executive Leadership Team.

Sigmund is board-certified in internal medicine with a subspecialty in cardiovascular diseases. Over the course of his career, he has led both small and large medical affairs organizations in the United States and globally.

Prior to joining BD, Sigmund served as senior vice president and country medical director of U.S. Medical Affairs at GlaxoSmithKline, where he was responsible for U.S. medical governance and oversight for all medical affairs activities. He began his industry career at Warner Lambert, where he served as vice president, Medical and Scientific Affairs. Following the merger between Warner Lambert and [Pfizer](/org/pfizer), Sigmund served as vice president, Worldwide Medical for [Pfizer](/org/pfizer). He also led the U.S. Medical Affairs organization at Daiichi-Sankyo.

Sigmund earned a medical doctorate (MD) degree from [West Virginia University](/org/west-virginia-university) and a master’s of health sciences (MHS) degree in epidemiology from [Johns Hopkins University](/org/johns-hopkins-university), where he completed his residency in internal medicine. Following his fellowship in cardiology at [Georgetown University](/org/georgetown-university), he returned to Johns Hopkins for a fellowship in preventive cardiology. He remained on faculty at Johns Hopkins as medical director of Preventive Cardiology programs until joining the pharmaceutical industry in 1990. He is a fellow of the [American College of Cardiology](/org/american-college-of-cardiology) (FACC), the College of Physicians (ACP) and the College of Physicians of Philadelphia.

William R. Sigmund

McCombs is responsible for continuing to drive the company's category innovation strategy and leading all research and development (R&D) activities, including executing the current innovation pipeline and developing the future product portfolio.

McCombs, who has more than 20 years of extensive experience in advanced medical device innovation, joined BD in 2019 as the senior vice president of R&D for the BD Medical Segment. She began her career at [Johnson & Johnson](/org/johnson-johnson) (J&J) Ethicon Endo-Surgery and progressed through positions of increasing leadership responsibility, including director for the J&J Corporate Office of Science and Technology (COSAT), focused on external technology partnerships; R&D leader for the J&J Sports Medicine business; vice president of Surgical Innovation for the Ethicon franchise; and most recently, as vice president of R&D for Ethicon, while also leading China R&D and Industrial Design/Human Factors for all of J&J Medical Devices.  Aside from her technical credentials, Beth has been recognized for her work driving inclusion and diversity efforts, including the support and mentorship of fellow female professionals.

McCombs holds both a Bachelor of Science and a Master of Science in Mechanical Engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the [University of Pennsylvania](/org/university-of-pennsylvania)'s Wharton School of Business.

Elizabeth McCombs

Vishy Kanda serves as senior vice president and chief strategy officer for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. Kanda is responsible for leading enterprise-wide strategic initiatives that will advance BD’s long-term growth strategy. He is also a member of the BD Executive Leadership Team.

Kanda also serves as senior vice president and head of strategy and business development for BD’s Medical Segment. Prior to that, he served in a range of strategy roles at BD including vice president and general manager for new commercial models, and vice president of strategy and innovation.

Before joining BD, Kanda spent 10 years in management consulting, most recently as an associate principal at [McKinsey & Company](/org/mckinsey-company), where he served global Fortune 500 healthcare corporations, delivering on a range of strategy and operations initiatives.

Kanda holds a Master of Science degree in Technology and Policy from the Massachusetts Institute of Technology (MIT), a Master of Business Administration from the Indian Institute of Management, and a Bachelor of Science degree in Chemical Engineering from the Indian Institute of Technology.

Vishy Kanda

Denise Fleming serves as chief information officer and executive vice president of technology and global services for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. Fleming is responsible for leading all aspects of BD’s IT systems and processes, the enterprise program management office and global shared service centers. She is also a member of the BD Executive Leadership Team.

Fleming joined BD from Boeing, where she was the vice president of IT and CIO of Boeing Defense, Space & Security, responsible for driving innovative digital solutions, cybersecurity compliance and managing the value delivery of IT systems for 30,000 Boeing associates. Prior to Boeing, Fleming held several positions at Sprint before joining BAE Systems, Inc. as VP, Business Technology & Application Solutions. She has more than 25 years of experience in IT, business transformation and technology solutions.

Fleming earned her Bachelor of Science degree in Electrical Engineering from the University of Virginia; a Master of Business Administration degree from Duke University, Fuqua School of Business; and received an Advanced General Manager’s Program certificate from Insead Business School in France.

She is also a co-founder and board member of TechPACT, a non-profit focused on increasing diversity in STEM. She is also a member of the Executive Leadership Council where she serves on the IT Advisory Committee, and a member of the Technical Advisory Board for Greycroft Venture Capital Firm. As an executive member of the IT Senior Management Forum, she mentors high potential talent selected for development programs offered by the organization. Fleming received the Career Achievement Award at the 2022 Black Engineer of the Year Award Conference and was also recognized by Diversity Woman Magazine as one of the Elite 100 in the Class of 2022. She has been featured in various publications including Forbes and US Black Engineer & IT Magazine.

Denise Fleming

Brown is currently the executive chair of [L3Harris](/org/l3harris) Technologies, a global aerospace and technology innovator with $18 billion in annual revenue and customers in more than 100 countries. Prior to this role, Brown served as chair and CEO of [L3Harris](/org/l3harris) from July 2019 to June 2021, after L3 and Harris merged in 2019. Prior to the merger, Brown served as chair, CEO and president of Harris. Prior to Harris, Brown spent 14 years at United Technologies Corporation (UTC) serving in a variety of leadership roles, including senior vice president of Corporate Strategy and Development and president of UTC Fire & Security. Brown also worked for McKinsey and Company earlier in his career.

Brown serves on the Celanese Corporation Board of Directors, the Fire Department of New York City Foundation Board and is a member of the Business Council. He is also the former chair of the Aerospace Industries Association (AIA) and was a member of AIA's Executive Committee.

Brown received his Bachelor and Master of Science degrees in mechanical engineering from [Villanova University](/org/villanova-university) and a Master of Business Administration from the Wharton School of the University of Pennsylvania.

William Brown

Brooke Story is the current Worldwide President of Integrated Diagnostic Systems at [Becton Dickinson](/org/becton-dickinson). Brooke has over twenty years of experience in the medical device industry. Prior to their current role, Ms. Story was the President of Pelvic Health and Gastric Therapies at [Medtronic](/org/medtronic) from May 2006 to March 2021. Brooke has also held the role of Manager for Sales Planning & Operations at Ethicon Endo-Surgery, a [Johnson & Johnson](/org/johnson-johnson) company, from January 1999 to June 2003. Ms. Story is a highly respected leader in the medical device industry, with a proven track record of success in both large and small organizations.

Brooke Story has a MBA from University of Michigan - Stephen M. Ross School of Business and a BS in Industrial Engineering from University of Tennessee, Knoxville.

Some of their coworkers include Puneet Sarin - Worldwide President, Biosciences. Brooke Story reports to Dave Hickey, EVP & President, Life Sciences Segment.

Brooke Story

Steve Conly

Puneet Sarin is the Worldwide President of Medication Management Solutions at [Becton Dickinson](/org/becton-dickinson). Puneet was previously the Senior Vice President & General Manager of the Chemistry & Immunoassay Business unit at [Beckman Coulter](/org/beckman-coulter-inc) from October 2016 to May 2019. Prior to that, they were the Vice President & General Manager of Pathology Imaging Business at [Leica Biosystems](/org/leicabiosystems) from June 2013 to October 2016. Before that, they were the GM of Sub-Acute Monitoring at [GE Healthcare](/org/ge-healthcare-limited) from September 2010 to June 2013. Puneet started their career at [GE Healthcare](/org/ge-healthcare-limited) as a Master Black Belt in Customer Loyalty (NPS) from May 2006 to June 2008.

Puneet Sarin has an MBA from [Emory University](/org/emory-university) and a BS in Mechanical Engineering from the [Milwaukee School of Engineering](/org/milwaukee-school-of-engineering).

Puneet Sarin reports to Dave Hickey, EVP & President, Life Sciences Segment. Puneet Sarin works with and Brooke Story - Worldwide President, Integrated Diagnostic Systems.

Puneet Sarin

Mischa Philleo is the Director of Marketing Technology Strategy at [Becton Dickinson](/org/becton-dickinson). Mischa has held this position since June 2020. Prior to that, they were the Director Marketing Technology Strategy at BD from September 2021 to June 2020. 

In their role as Director of Marketing Technology Strategy, Mischa is responsible for leading digital marketing technology strategy globally. This includes simplifying and modernizing the company's digital marketing technologies and associated people and processes to drive commercial excellence, e-commerce, create competitive advantage, and accelerate sustainable, profitable growth. 

Under Mischa's leadership, the company has streamlined its martech stack from over 30 suppliers down to 4 strategic partnerships, resulting in immediate cost savings of over $3MM in license costs. The closed loop ecosystem that Mischa has created has enabled the company to track wing-to-wing ROI. In response to COVID-19, Mischa has also created digital agile teams to respond quickly to customer needs. This has included the implementation of Salesforce.com + Marketo integration for customer lead generation and ROI measurement; digital communications channels and platforms (e.g. Showpad for allowing sales force to communicate with customers in a scalable way); and digital training platforms to educate customers on new rapid COVID-19 diagnostic products. 

Mischa has also delivered a future state omni-channel commercial transformation strategy that aligned to business goals and drivers. This has resulted in a revenue increase of $100M

Mischa Philleo received a Bachelor of Arts in Economics and Philosophy from the University of Michigan.

Mischa Philleo works with Ray Gomez - Director of Digital Marketing, Channel & Content Strategy, Robin Lyng - Manager, Marketing Communication & Digital Marketing, and Richard Lockhart - Director of Campaign Analytics & Automation. Mischa Philleo reports to Robin Blackburn, VP, Digital Marketing.

Mischa Philleo

John Iannetta is the Vice President of Commercial Operations at [Becton Dickinson](/org/becton-dickinson). John has held this position since July 2014, and in this role they are responsible for leading the Commercial Operations Center of Excellence. This team is dedicated to providing superior customer service and performance, as well as harmonized and improved processes and policies. They work with business leaders across the company to deliver an improved customer experience.

Prior to their current role, John was with Commercial Operations Excellence LLC, where they served as the Director of Business Development. In this role, they were responsible for identifying and developing new business opportunities, as well as managing relationships with existing clients. John also worked with Community Hope, where they served as the Director of Housing Programs. In this role, they were responsible for overseeing the organization's housing programs and ensuring that they met the needs of the community.

John Iannetta has a Bachelor of Science in Electrical Engineering - Biomedical Engineering from [Rutgers University](/org/rutgers-university). John is also Six Sigma Certified Black Belt from GE and Philips Lighting.

John Iannetta works with Steve Gundersen - VP & GM, SCG, Ryan Tuttle - Senior Director of Innovative Commercial Models, and Kathy Sullivan - VP, Commercial Effectiveness & Marketing Operations. John Iannetta reports to Tony Ezell, EVP, North America & Chief Marketing Officer.

John Iannetta

Patricia Brennan is the current Associate Director of Meetings & Events for the US Region at [Becton Dickinson](/org/becton-dickinson). Patricia has over 25 years of experience in marketing communications and public affairs. Patricia has a long history of working in the healthcare industry, with their most recent position being Vice President of Healthcare Practice at Gennera Knab & Company. In this role, they were responsible for new business development, website development, and advertising campaigns. Prior to this, Patricia served as the Senior Brand Manager and Director of Marketing Communications at BlueCross BlueShield Association. In these roles, they were responsible for brand positioning, corporate sponsorships, and business-to-business brand strategy. Patricia began their career in 1991 as a Marketing Communications Specialist at Children’s Memorial Medical Center (now Lurie Children’s). Patricia eventually rose to the position of Director/Senior Associate/Associate over the course of their eight-year tenure.

Patricia Brennan graduated from [Marquette University](/org/marquette-university) with a Bachelor of Arts in Journalism. Patricia then went on to earn their Masters of Public Health from the University of Illinois Chicago in the field of Community Health Sciences. Patricia also has a certification from [Duke University](/org/duke-university) in Digital Media and Marketing.

Patricia Brennan works with Christine Snyder - VP, Corporate Marketing, Steve Gundersen - VP & GM, SCG, and Ryan Tuttle - Senior Director of Innovative Commercial Models. Patricia Brennan reports to Tony Ezell, EVP, North America & Chief Marketing Officer.

Patricia Brennan

Ryan Tuttle is the Senior Director of Innovative Commercial Models at [Becton Dickinson](/org/becton-dickinson). Ryan has been with BD since 2006, and in their current role, they are responsible for developing new commercial models with leading US Health Systems. Prior to their current role, Ryan served as the Sr Marketing Director US Region, Sr Global Marketing Director IV Access, Global Marketing Director - Preanalytical Systems, and Director of US Marketing. In their previous roles, they led the strategic marketing function to initiate a new business platform in insulin infusion and was responsible for the BD Vacutainer Chemistry Tube Portfolio. Ryan has a proven track record in developing and executing marketing strategies that drive business growth.

Ryan Tuttle has a MBA in Marketing & Finance from Cornell University - S.C. Johnson Graduate School of Management, a BSBA in Management from Bucknell University, and a certification from Certified Management Accountant (Not Active).

Some of their coworkers include Steve Gundersen - VP & GM, SCG, Robin Blackburn - VP, Digital Marketing, and Kathy Sullivan - VP, Commercial Effectiveness & Marketing Operations. Ryan Tuttle reports to Tony Ezell, EVP, North America & Chief Marketing Officer.

Ryan Tuttle

David Wild is the current Director of Digital Marketing at [Becton Dickinson](/org/becton-dickinson). Prior to this, they held the position of Marketing and Communications Committee Chair at Society for Imaging Informatics in Medicine (SIIM) from January 2014 to August 2017. In this role, David was responsible for increasing awareness of SIIM, enhancing its reputation, recruiting new members, retaining existing members, and encouraging participation in SIIM activities. David also provided guidance in the marketing of programs and services to members, researched new target audiences and segments, developed and implemented marketing strategies, and developed collaborative relationships and partnerships with vendors.

Before their time at SIIM, David worked as the Senior Director of Marketing for Radiology Informatics at FUJIFILM Medical Systems U.S.A., Inc. from September 2006 to August 2017. In this role, they oversaw the downstream marketing group for Fujifilm Synapse Radiology software portfolio, which represented 4,500 clients globally across four product lines: Radiology PACS, RIS, 3D, and Communications. David was responsible for strategic planning for healthcare informatics software portfolio, channel management, developing strategic messaging and communications for each phase of the buyer's journey, leading software product commercialization and pricing strategy, managing the field service marketing team, supporting society messaging and trade show experience, and leading product development lifecycle for software releases. David also managed the creation of customer-facing sales collateral, the product release schedule, the product website, and

David Wild studied policy studies as an undergraduate at [Syracuse University](/org/syracuse-university). David then went on to complete a certification from the CITI Program in Biomedical Research.

Their manager is Robin Blackburn, VP, Digital Marketing. They are on a team with Kenny Eicher - Creative Director, Nazish Amir-Siddiqi - Director of Web Management & Data Governance, and Yuliya Vexler - Senior Administrative Assistant.

David Wild

Robin Lyng is the Manager of Marketing Communication & Digital Marketing at [Becton Dickinson](/org/becton-dickinson). Robin has over fifteen years of experience in project management, financial reporting, vendor contract/relations, system operations, and print/fulfillment services. Robin is responsible for budget and forecast management, strategic sourcing, timeline negotiation, and continuous improvements with an emphasis on efficient operations, metrics and KPIs and delivering results through a team environment.

Previously, Robin worked for BD as the Production Manager for Creative Services. In this role, they worked with Project Managers and Designers to produce marketing collateral to promote business development and product launches. Robin also interacted directly with inhouse and outside vendors on printing and manufacturing high quality, cost effective deliverables. Robin has over ten years experience in digital and offset printing, with both production and marketing materials. Robin has detailed working knowledge of color proofing, bindery methods, and paper selections.

Robin Lyng has an associates degree in business administration from Centenary University. Robin also has a certification from LinkedIn in Excel: PivotTables for Beginners.

Robin Lyng reports to Robin Blackburn, VP, Digital Marketing. and Victor Wei (C) - Proofreader reports to Robin Lyng. Some of their coworkers include Mischa Philleo - Director of Marketing Technology Strategy, Ray Gomez - Director of Digital Marketing, Channel & Content Strategy, and Kenny Eicher - Creative Director.

Robin Lyng

Claire M. Fraser is the current director at [Becton Dickinson](/org/becton-dickinson). Fraser has over fifteen years of experience in quality engineering and management. Fraser started their career as a quality engineer intern at [Motorola](/org/motorola) before being promoted to quality engineering manager at Bard Peripheral Vascular. Fraser has been with [Becton Dickinson](/org/becton-dickinson) since February 2004 and has served as the director since December 2017.

Claire M. Fraser has an MBA from the W. P. Carey School of Business – [Arizona State University](/org/arizona-state-university) with an emphasis in international business. Claire also has a B.S.E. from [Arizona State University](/org/arizona-state-university) in industrial engineering.

Claire M. Fraser

Robert Krejci

Padraic O'Brien is the current Worldwide President, Peripheral Intervention at [Becton Dickinson](/org/becton-dickinson). Prior to this role, they served as Vice President, General Manager at BD Peripheral Intervention from February 2019 to October 2020. Padraic has also held various other leadership positions at Bard Peripheral Vascular, Bard Biopsy Systems, and Bard Access Systems. Padraic began their career in 1997 as an Area District Manager at ADP.

Padraic O'Brien has a Bachelor of Science from [Santa Clara University](/org/santa-clara-university) and attended [Marquette University](/org/marquette-university) High School.

Their manager is Simon D. Campion, EVP & President, Medical Segment. They work with Kevin Kelly - Worldwide President, Surgery, Richard Byrd - Worldwide President, Medication Delivery Solutions, and Rima Alameddine - Worldwide President, Urology & Critical Care.

Padraic O'Brien

Kevin Kelly is the current Worldwide President of Surgery at [Becton Dickinson](/org/becton-dickinson). Prior to this, they were the President at CR Bard from May 2010 to January 2018. Kevin has also held VP positions at [SmartPill](/org/smartpill) and Accellent. Kevin started their career in 1999 at Accellent as the VP of Market Development. In 2004, they moved to [LeMaitre Vascular](/org/lemaitre-vascular) as the VP of Sales and then to [SmartPill](/org/smartpill) in 2008. Kevin has been with [Becton Dickinson](/org/becton-dickinson) since 2018.

Kevin Kelly holds an MBA from [Harvard Business School](/org/harvard-business-school), an MS in engineering from [Tufts University](/org/tufts-university), and a BS in engineering from [Tufts University](/org/tufts-university). Kevin also attended St. John's Prep.

Kevin Kelly reports to Simon D. Campion, EVP & President, Medical Segment. Kevin Kelly works with Rima Alameddine - Worldwide President, Urology & Critical Care, Padraic O'Brien - Worldwide President, Peripheral Intervention, and Michael Garrison - Worldwide President, Medication Management Solutions.

Kevin Kelly

Rima Alameddine is the Worldwide President, Urology & Critical Care at [Becton Dickinson](/org/becton-dickinson). Rima was previously the Vice President & General Manager, Latin America at CR Bard from May 2015 to January 2018. Prior to that, they were the Chief Marketing Officer - Latin America at [GE Healthcare](/org/ge-healthcare-limited) from June 2008 to May 2015. Rima also held the position of XR/ WHC Product Manager at [GE Healthcare](/org/ge-healthcare-limited) from May 2004 to August 2007. Before that, they were the International Sales Manager at Fresenius Group from September 2000 to May 2004.

Rima Alameddine has a Doctor of Pharmacy from Universidade de São Paulo and has studied pharmacy and biochemistry. Rima also has degrees from ESPM Escola Superior de Propaganda e Marketing in both propaganda and marketing. Finally, they have a degree from GE Crotonville.

Rima Alameddine works with Richard Byrd - Worldwide President, Medication Delivery Solutions, Michael Garrison - Worldwide President, Medication Management Solutions, and Kevin Kelly - Worldwide President, Surgery. Rima Alameddine reports to Simon D. Campion, EVP & President, Medical Segment.

Rima Alameddine

Dr. Michael Garrison serves as executive vice president and president of the Medical Segment of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he is responsible for driving the global operational, commercial and financial performance of the three business units that comprise BD’s largest segment, including BD Medication Delivery Solutions, BD Medication Management Solutions and BD Pharmaceutical Systems. He is also a member of the BD Executive Leadership Team.

Dr. Garrison most recently served as worldwide president of BD Medication Management Solutions. In this role, he advanced BD 2025 priorities and drove growth through next-generation solutions supporting BD’s commitment to Smart, Connected Care and New Care Settings. He also led the team responsible for advancing BD’s 510(k) submission for Alaris. Additionally, he oversaw several successful tuck-in M&A deals, including the recent acquisition of Parata Systems – BD’s largest acquisition since Bard in 2017.

Since joining BD in 2005, Dr. Garrison has led teams with deep industry knowledge, operational excellence and a global view. He has a track record of building high-performing teams, applying a customer perspective to his work and driving growth. He previously served as worldwide president of the BD Surgery business unit, vice president and general manager of Infusion Systems, vice president of Research and Development (R&D) for BD Medication Delivery Solutions and Greater Asia and other earlier roles in R&D and platform leadership.

Dr. Garrison earned a Ph.D. in Bioengineering from the University of Washington and Bachelor and Master of Science degrees in Biomedical and Electrical Engineering from Duke University. He is an associate adjunct professor of Bioengineering at the University of Washington and a member of the University of Washington Department of Bioengineering Industrial Advisory Board and the Advisory Board of the Center for Dialysis Innovation.

Dr. Garrison is also a member of the Board of Governors for Biocom California, the association representing the California life sciences industry.

Michael Garrison

Richard Byrd serves as executive vice president and president of the Interventional Segment of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he is responsible for driving the global operational, commercial and financial performance of the three business units that comprise the Interventional Segment, including BD Peripheral Intervention, BD Surgery and BD Urology and Critical Care. He is also a member of the BD Executive Leadership Team.

Byrd most recently served as the worldwide president of BD Medication Delivery Solutions within the Medical segment. In that role, Byrd advanced BD’s leadership in Vascular Access Management, completing the integration of the Bard portfolio and driving a strong innovation pipeline. During the COVID-19 pandemic, he oversaw BD’s role in enabling global COVID-19 vaccination campaigns, including commitments of more than two billion injection devices worldwide. He also advanced BD’s “One-Stick Hospital Stay” vision to eliminate multiple needlesticks for in-patients and drive a new standard of care in vascular health.

Since joining BD in 2004, Byrd has demonstrated a proven track record of leveraging his strength in technology and innovation to drive growth while prioritizing customers’ needs, delivering operational efficiencies and developing talent across the globe. He previously held leadership roles within BD Life Sciences segment and Research and Development.

Byrd earned a master's degree in Mechanical Engineering from Stevens Institute of Technology and a Bachelor of Science degree in Mechanical Engineering from Virginia Tech.

Richard Byrd

Carla Burigatto is the SVP, Chief Communications Officer at [Becton Dickinson](/org/becton-dickinson). Carla has over 20 years of experience in communications and public relations, working with companies in the science, energy, technology, health care and consumer industries. Carla began their career as a Communications Assistant at the Recording Industry Association of America before moving on to Gibbs & Soell Public Relations, where they eventually became an Account Supervisor. In 2001, they joined [AstraZeneca](/org/astrazeneca) as their Corporate Affairs Director for the Northeast region. After seven years with the company, they left to start their own communications and marketing consultancy. In 2012, they were recruited by [Campbell Soup Company](/org/campbell-soup-company) to head up their external communications department. Carla remained with the company for five years before joining [Haemonetics](/org/haemonetics) as their Vice President of Global Communications in 2017. Carla has been with [Becton Dickinson](/org/becton-dickinson) since June 2021.

Carla Burigatto attended the MIT Sloan School of Management and the Massachusetts Institute of Technology before completing their education at [Georgetown University](/org/georgetown-university).

Carla Burigatto reports to Tom Polen, Chairman, CEO & President. Some of their coworkers include Michelle Quinn - SVP, Deputy General Counsel, Chief Ethics & Compliance Officer & Chief Regulatory Counsel, David Shan - EVP, Chief Quality Officer, and Tony Ezell - EVP, North America & Chief Marketing Officer.

Carla Burigatto

Michelle Quinn is the Senior Vice President, Deputy General Counsel, Chief Ethics & Compliance Officer & Chief Regulatory Counsel at [Becton Dickinson](/org/becton-dickinson). Michelle has over 25 years of experience in the legal field.

Michelle started their career as a Litigation Associate at Morgan, Lewis & Bockius LLP from August 1993 to August 1997. Michelle then joined Groupe Soparind Bongrain (now Group Savencia) as Corporate Intellectual Property & Regulatory Counsel - North America from September 1997 to February 2010. In February 2010, they joined Catalent Pharma Solutions as Vice President, Associate General Counsel and was responsible for regulatory affairs, litigation and commercial matters. Michelle served in this role till February 2015.

In February 2015, Michelle Quinn joined Sandoz Inc., a division of [Novartis](/org/novartis), as Vice President, General Counsel, North America. Michelle served in this role for four years till January 2019. Presently, they are working as the Senior Vice President, Deputy General Counsel, Chief Ethics & Compliance Officer & Chief Regulatory Counsel at [Becton Dickinson](/org/becton-dickinson) since January 2019.



Some of their coworkers include Carla Burigatto - SVP, Chief Communications Officer, William R. Sigmund - EVP, Chief Medical Officer, and Christopher DelOrefice - EVP, CFO. Michelle Quinn reports to Tom Polen, Chairman, CEO & President.

Michelle Quinn

Gregory Rodetis is the SVP, Treasurer at [Becton Dickinson](/org/becton-dickinson). Gregory was previously the Assistant Treasurer at Terex Corporation from January 2014 to December 2016. Prior to that, they were the Treasury Director at [PepsiCo](/org/pepsico) from January 2008 to December 2014, where they managed capital markets, commodities, and FX & international treasury. Gregory started their career as a Treasury Manager - FX & Commodities at General Electric Company in January 2000 and held that position until December 2008.

Gregory Rodetis began their educational career by obtaining a BS in finance from [Boston College](/org/boston-college). Gregory then went on to obtain their certification from the [CFA Institute](/org/cfa-institute) as a CFA Charterholder.

Some of their coworkers include Kristen Stewart - SVP, Strategy & Investor Relations, Thomas Spoerel - SVP, Controller & Chief Accounting Officer. Gregory Rodetis reports to Christopher DelOrefice, EVP, CFO.

Gregory Rodetis

David Shan serves as executive vice president and chief quality officer for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. He is also a member of the BD Executive Leadership Team.

Shan joined BD in 2015 and has continued to advance his career and learning by rotating across multiple functions and businesses. He first served as VP of Global Operations for the Pharmaceutical Systems business, before taking on expanded responsibility leading operations for several of BD’s devices businesses. Most recently, he served as senior vice president of global supply chain, where he strengthened the function to be more agile and customer focused, adding new systems and technologies, optimizing our distribution and logistics network, and improving delivery time to customers.

Before joining BD, Shan served as Chief Operating Officer for SGD Pharma, overseeing quality, manufacturing operations, R&D and supply chain, among other functions. He previously led global quality and operational excellence for Graham Packaging, a company with 84 plants in 16 countries, where he integrated and deployed a single global Quality Management System and delivered significant reductions in customer complaints. He began his career at 3M, where he received his Six Sigma Black Belt certification and held multiple positions including technical services and plant quality manager.

David Shan

Tom Polen is chairman, chief executive officer and president of BD (Becton, Dickinson and Company), an innovative global medical technology company headquartered in Franklin Lakes, New Jersey. Since taking the leadership reins in early 2020, he has focused the organization’s BD 2025 strategy around three pillars—Grow, Simplify, and Empower—which drive and accelerate the innovation of advanced, cutting-edge technologies like smart connected devices, and the high performance of a diverse team of 70,000 associates who approach their work with a growth mindset. He puts a strong emphasis on the impact BD’s associates make by doing things The BD WAY every day and fulfilling the company’s purpose of advancing the world of health.

Polen originally came to BD in 1999 through the acquisition of an early phase start-up. In 2004, he joined Baxter Healthcare, where his last role was a leading Baxter’s Injectable Pharmaceuticals business. He returned to BD as president of BD Preanalytical Systems in 2009; as segment president, BD Medical, Polen led the $12 billion acquisition of CareFusion in 2015, spearheading the company’s expansion into informatics and digital health solutions. Shortly after leading the strategy for the $24 billion acquisition of C. R. Bard, Inc. in 2017, he was named president and chief operating officer. Polen became chief executive officer in January 2020 and chairman of the board of directors in April 2021.

Polen serves on the board of directors of [AdvaMed](/org/advamed), where he is a member of the T&R Committee. He is also on the boards of directors of the Hackensack Meridian Health Foundation and the Hackensack Meridian Health Center for Discovery and Innovation (CDI), and is a member of the American Heart Association CEO Roundtable. He is active in support of Children’s Tumor Foundation, as well as a number of national and local associations committed to helping patients with breast cancer.

Polen earned his bachelor’s degree from the Salisbury University of Maryland and a master’s degree in business administration from Johns Hopkins University.

Tom Polen

Sam Khichi serves as executive vice president, corporate development, public policy, regulatory affairs and general counsel. He is also a member of the BD Executive Leadership Team.

Prior to his current role, Khichi served as senior vice president and general counsel of C. R. Bard, Inc., a leading medical technology company in the fields of vascular, urology and surgical specialty products, which BD acquired in 2017.

Khichi’s prior experience includes serving as senior vice president, chief administrative officer and general counsel for Catalent Pharmaceutical Solutions; counsel at O’Melveny & Myers LLP, specializing in mergers, acquisitions and private equity; and mergers and acquisitions attorney at Shearman & Sterling.

He also previously served as a reserve officer in the United States Navy, an active duty field artillery officer in the [United States Army](/org/united-states-army) and a White House Fellow appointed by President George W. Bush.

Khichi earned a bachelor’s degree in business from [Georgetown University](/org/georgetown-university), a juris doctorate in law from Fordham University School of Law and a master’s degree in business administration from the Northwestern University Kellogg School of Management.

Sam Khichi

Ami E. Simunovich serves as senior vice president and chief regulatory officer for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. She is also a member of the BD Executive Leadership Team.

Prior to her current role, Simunovich served as chief regulatory counsel, advising in the management of complex global regulatory law and international regulatory legal matters.

Simunovich previously served as associate general counsel of regulatory and compliance, at C. R. Bard, Inc., a leading medical technology company in the fields of vascular, urology and surgical specialty products, which BD acquired in 2017. Prior to Bard, Simunovich was associate general counsel of regulatory at Catalent, Inc., a Blackstone Portfolio Company and global contract manufacturer of pharmaceuticals, biologics and dietary supplements. She also has served as legal counsel in litigation, regulatory law and intellectual property at New York-based law firm, Frommer Lawrence & Haug (now [Haug Partners](/org/haug-partners)).

Ami E. Simunovich

Meg Walter

Lisa Doorly

Jessica Poggi

Maria Semyonova

Rick Daniel

Shana Neal serves as executive vice president and chief people officer for BD (Becton, Dickinson and Company), a leading global medical technology company based in Franklin Lakes, New Jersey. Neal is a veteran executive who specializes in leading organizational growth and transformation, and is responsible for leading the human resources, communications and social investing functions. She is also a member of the BD Executive Leadership Team.

Neal previously served as chief human resources officer of [Owens & Minor](/org/owens-minor), a global healthcare solutions company that provides integrated technology, products and services across the continuum of care, leading all aspects of human resources as well as serving as President of the [Owens & Minor](/org/owens-minor) Foundation and executive sponsor for ESG. A champion for authentic leadership, Neal joined [Owens & Minor](/org/owens-minor) to integrate a series of acquisitions made by the company, build a transformational human resources organization and lead in the effort to transform [Owens & Minor](/org/owens-minor) into a global organization.

Prior to joining [Owens & Minor](/org/owens-minor), Neal served as senior vice president, human resources for BD where she helped lead the two largest acquisitions in the company’s history and was accountable for developing the talent, culture and organizational design of the expanded organization to advance its strategy and impact.

Neal holds an M.A. in Human Resources Development from [Clemson University](/org/clemson-university) and completed [Columbia University](/org/columbia-university)’s Executive Education Program in Strategic Impact. She currently serves on the Board of Directors for Virginia Health Information.

Shana Neal

She most recently led the medical technology research franchise at Barclays Capital. She has been recognized by Institutional Investor as one of the top three analysts in the Medical Supplies & Devices category several times during her career.

Kristen Stewart

Pavan Mocherla serves as executive vice president and president of the Greater Asia region for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. He is also a member of the BD Executive Leadership Team. Based in Singapore, Mocherla leads the company’s business operations in China, Japan, Taiwan, Hong Kong, Australia, New Zealand, Korea, Southeast Asia, India/South Asia and Pakistan.

Mocherla joined BD in 2003 and has since served in leadership roles across country, region and worldwide roles. He has progressed from sales to general management, most recently as the country general manager of South Asia. Prior to that, he held leadership roles including VP of Strategic Innovation for Greater Asia, worldwide platform leader of the Specimen Management Containment Business Platform in Franklin Lakes, NJ, and business director of Pre-Analytical Systems for regions including South Asia, as well as residing in the Middle East where he led the Commonwealth of Independent States (CIS), Middle East and Africa.

Prior to joining BD, he was general manager of sales for Whirlpool in Chennai, India, where he led teams in the Tamil Nadu and Kerela regions overseeing sales, commercial and trade marketing.

Mocherla earned his Bachelor of Science from Osmania University and a Master of Business Administration in Marketing and General Management from Pondicherry University in India.

Pavan Mocherla

Experienced Senior Vice President Human Resources with a demonstrated history of working in the medical device industry. Strong human resources professional skilled in Human Resources, Organizational Design, Talent Management, Organizational Effectiveness, and Performance Management. 

Thomas Ruddy

Thomas Spoerel is the Senior Vice President, Controller, and Chief Accounting Officer at [Becton Dickinson](/org/becton-dickinson). Thomas has over fifteen years of experience in finance and accounting. 

Spoerel began their career at Arthur Andersen as a Staff II in the Audit Department. Thomas then transitioned to Ernst & Young LLP, where they progressed through the ranks to Senior Manager. In 2009, they joined [Catalent](/org/catalent) as Vice President of Finance and Corporate Controller. Thomas held this position for six years before joining [Becton Dickinson](/org/becton-dickinson) in 2015. 

Spoerel is a Certified Public Accountant and holds a Bachelor’s degree in Accounting from [Rutgers University](/org/rutgers-university).

Thomas Spoerel's educational career includes receiving an MBA from Columbia Business School and a BS in Public Accounting from [Fordham University](/org/fordham-university). Thomas also attended CHAMINADE.

Thomas Spoerel reports to Christopher DelOrefice, EVP, CFO. They work with Gregory Rodetis - SVP, Treasurer, Kristen Stewart - SVP, Strategy & Investor Relations.

Thomas Spoerel

Victor Wei (C)

Tracy Solowski (C)

Joanna Wagner

Sophie Penkrat (C)

Kenny Eicher

Rodrigo Luiz Hanna

Dr. Carrie L. Byington serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Dr. Byington has been a member of the board since 2021.

Dr. Byington serves as the Executive Vice President and head of University of California Health (UCH), where she leads the nation's largest academic health system. Prior to UCH, Dr. Byington held leadership roles at Texas A&M University System, including serving concurrently as dean of the College of Medicine and senior vice president of Health Sciences for Texas A&M University and vice chancellor for health services for the Texas A&M 11-campus system. She is the first Hispanic woman to serve in these health leadership roles in the United States. Prior to Texas A&M University System, she spent more than 20 years in teaching and leadership positions with the University of Utah.

Dr. Byington has received awards from the Robert Wood Johnson Foundation, the American Academy of Pediatrics, the Centers for Disease Control and Prevention, the National Institutes of Health and Drexel University College of Medicine's Institute for Women's Health and Leadership. Her research has focused on respiratory pathogens, molecular diagnostics and pandemic preparedness. She is an elected member of the National Academy of Medicine and National Academy of Inventors. She was the Chair of the Infectious Diseases Advisory Group for the U.S. Olympic Committee, responsible for protecting Team USA athletes and staff from the Zika Virus during the 2016 Olympic Games in Brazil. She is board certified in General Pediatrics and Pediatric Infectious Diseases. Through her leadership positions at some of the nation’s largest health systems, Dr. Byington brings extensive knowledge and perspective regarding the integrated delivery of healthcare services. She also possesses strong executive management skills and strategic planning experience, as well as expertise in clinical practice and infectious diseases.

Carrie L. Byington

Christopher DelOrefice is the Executive Vice President and Chief Financial Officer at Becton Dickinson.

DelOrefice, 50, joined BD from Johnson & Johnson (J&J), where he was vice president of Investor Relations. In nearly two decades at J&J, DelOrefice has also held a variety of senior finance leadership roles, including CFO of both the Consumer and Medical Devices segments for North America. He also held finance leadership roles for J&J Supply Chain, Corporate Mergers and Acquisitions, Consumer Global R&D and the Pharmaceutical North America Business Development and Commercial Contracting Finance groups. Prior to J&J, DelOrefice held leadership positions in cost accounting, global audit and financial reporting at Astra Zeneca Pharmaceuticals, AET Films, Inc. and Ametek, Inc.

DelOrefice earned his Bachelor of Science and Master of Business Administration degrees from Villanova University. He received his certified public accountant certification from the Commonwealth of Pennsylvania. He is a member of the Global Investor Relations Executive Council and also remains actively engaged in education and development initiatives at Villanova University.

Christopher DelOrefice

Roland Goette serves as executive vice president and president of the Europe, Middle East and Africa (EMEA) region for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey.  He is also a member of the BD Executive Leadership Team.

Goette joined BD in 2000 as European marketing manager for Flow Cytometry. He then was named to a number of roles with increasing responsibility, including serving as business director of the BD Biosciences business in Eastern Europe, Middle East and Africa, and as vice president (VP) and general manager (GM) of BD Medical Surgical Systems for Central and South Asia. In this role, he spent three years in Singapore, and then was named VP/GM of Medical Surgical Systems in Europe.

Roland Goette

Greg Miziolek

Bertram L. Scott

Dave Hickey serves as executive vice president and president of the Life Sciences segment of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he oversees the global operational, commercial and financial performance of the two businesses that comprise the Life Sciences segment: Integrated Diagnostic Solutions and BD Biosciences.

Hickey joined BD in 2014 as vice president and general manager for the Clinical Microbiology business. In 2016, he was promoted to president of the Diagnostics Systems business, and in 2019, to worldwide president of the newly formed Integrated Diagnostic Solutions unit, which brought together the strengths of the Diagnostic Systems and Preanalytical Systems businesses. Under Hickey’s leadership, IDS became instrumental in the global fight against SARS-CoV-2 (COVID-19), overseeing the development, launch, manufacturing and distribution of critical molecular and rapid point-of-care tests as well as critical swabs and viral transport systems.

Prior to BD, Hickey spent 22 years with Siemens Healthcare Diagnostics in multiple positions of increasing responsibility, including his last four years as CEO of its Central Laboratory Business Unit.

Dave is an active participant on the boards of directors for AdvaMedDx, Greater Baltimore Committee, Johns Hopkins Bloomberg School of Public Health, and the University of Maryland, Baltimore (UMB) Health Sciences Research Park.

Becton Dickinson

Org chart

Teams

CEO and Executive Team

Leadership Team

Board of Directors

Discover similar companies